Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls

被引：0
作者：
A Szpechcinski
M Dancewicz
P Kopinski
J Kowalewski
J Chorostowska-Wynimko
机构：
[1] National Institute of Tuberculosis and Lung Diseases,Laboratory of Molecular Diagnostics and Immunology
[2] Center of Oncology,Department of Thoracic Surgery and Tumors
[3] Nicolaus Copernicus University,Chair Gene Therapy, Collegium Medicum
来源：
European Journal of Medical Research | / 14卷
关键词：
DNA quantification; free-circulating DNA; lung cancer; plasma; real-time PCR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Characterisation and predictive value of epidermal growth factor receptor status using quantitative real-time PCR combined with immunohistochemistry on non-small cell lung cancer specimens
    Hilbe, W
    Dlaska, M
    Dirnhofer, S
    Duba, HC
    Eisterer, W
    Oberwasserlechner, F
    Mildner, A
    Schmid, T
    Ammann, K
    Thaler, J
    Wöll, E
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (04) : 893 - 899
  • [32] Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer
    Ulivi, Paola
    Silvestrini, Rosella
    CELLULAR ONCOLOGY, 2013, 36 (06) : 439 - 448
  • [33] Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients
    Bach, Sander
    Wever, Birgit M. M.
    van de Wiel, Mark A.
    Veltman, Joris D.
    Hashemi, Sayed M. S.
    Kazemier, Geert
    Bahce, Idris
    Steenbergen, Renske D. M.
    EPIGENETICS, 2022, 17 (10) : 1057 - 1069
  • [34] Bronchial Colonization in Patients with Non-Small Cell Lung Cancer
    Stojanovic, Ana
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2015, 32 (02) : 147 - 154
  • [35] Evaluation and Treatment of Patients with Non-Small Cell Lung Cancer
    Carr, Laurie L.
    Finigan, James H.
    Kern, Jeffrey A.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (06) : 1041 - +
  • [36] Microbiota Diversity in Non-Small Cell Lung Cancer Gut and Mouth Cavity Microbiota Diversity in Non-Small Cell Lung Cancer Patients
    Brisudova, Aneta
    Bielnikova-Krystofova, Hana
    Motyka, Oldrich
    Fritzova, Dominika
    Katuchova, Vladimira
    Ponikelska, Natalie
    Skanderova, Daniela
    Raclavsky, Vladislav
    Michalek, Jaroslav
    Mittak, Marcel
    Svecova, Petra
    Jakubec, Petr
    Rozsivalova, Denisa
    Szkorupa, Marek
    Klein, Jiri
    Skarda, Jozef
    Kolar, Zdenek
    Skopelidou, Valeria
    POLISH JOURNAL OF MICROBIOLOGY, 2023, 72 (04) : 467 - 475
  • [37] Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
    Sirera, Rafael
    Bremnes, Roy M.
    Cabrera, Andrea
    Jantus-Lewintre, Eloisa
    Sanmartin, Elena
    Blasco, Ana
    del Pozo, Nieves
    Rosell, Rafael
    Guijarro, Ricardo
    Galbis, Jose
    Javier Sanchez, Jose
    Camps, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) : 286 - 290
  • [38] Possible application of circulating free tumor DNA in non-small cell lung cancer patients
    Karachaliou, Niki
    Sosa, Aaron E.
    Angel Molina, Miguel
    Centelles Ruiz, Margarita
    Rosell, Rafael
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1364 - S1372
  • [39] Plasma von Willebrand factor antigen levels in non-small cell lung cancer patients
    Martini, F
    Ferroni, P
    Guadagni, F
    Basili, S
    Spila, A
    D'Alessandro, R
    Mineo, D
    Laudisi, A
    Portarena, I
    Mariotti, S
    Ambrogi, V
    Mineo, TC
    Roselli, M
    ANTICANCER RESEARCH, 2005, 25 (1B) : 403 - 407
  • [40] Detection of EGFR mutations in plasma and biopsies from non-small cell lung cancer patients by allele-specific PCR assays
    Britta Weber
    Peter Meldgaard
    Henrik Hager
    Lin Wu
    Wen Wei
    Julie Tsai
    Azza Khalil
    Ebba Nexo
    Boe S Sorensen
    BMC Cancer, 14
12345